AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

List of Medrio CDMS/EDC Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Old Product New Product Category When SI
Atlantic Research Group Professional Services 10 $1M United States Medrio Legacy Medrio CDMS/EDC Clinical Trial Management 2023 n/a
Nevro Life Sciences 1087 $406M United States Medrio Legacy Medrio CDMS/EDC Clinical Trial Management 2023 n/a
Showing 1 to 2 of 2 entries

Buyer Intent: Companies Evaluating Medrio CDMS/EDC

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Medrio CDMS/EDC. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Medrio CDMS/EDC Coverage

Medrio CDMS/EDC is a Clinical Trial Management solution from Medrio.

Companies worldwide use Medrio CDMS/EDC, from small firms to large enterprises across 21+ industries.

Organizations such as Nevro and Atlantic Research Group are recorded users of Medrio CDMS/EDC for Clinical Trial Management.

Companies using Medrio CDMS/EDC are most concentrated in Life Sciences and Professional Services, with adoption spanning over 21 industries.

Companies using Medrio CDMS/EDC are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Medrio CDMS/EDC across Americas, EMEA, and APAC.

Companies using Medrio CDMS/EDC range from small businesses with 0-100 employees - 50%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 0%.

Customers of Medrio CDMS/EDC include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Medrio CDMS/EDC customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.